JP2007502785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502785A5 JP2007502785A5 JP2006523530A JP2006523530A JP2007502785A5 JP 2007502785 A5 JP2007502785 A5 JP 2007502785A5 JP 2006523530 A JP2006523530 A JP 2006523530A JP 2006523530 A JP2006523530 A JP 2006523530A JP 2007502785 A5 JP2007502785 A5 JP 2007502785A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- propyl
- methyl
- chloro
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49673803P | 2003-08-21 | 2003-08-21 | |
| DKPA200301198 | 2003-08-21 | ||
| PCT/DK2004/000547 WO2005018676A1 (en) | 2003-08-21 | 2004-08-18 | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502785A JP2007502785A (ja) | 2007-02-15 |
| JP2007502785A5 true JP2007502785A5 (enExample) | 2007-09-20 |
Family
ID=34219531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523530A Withdrawn JP2007502785A (ja) | 2003-08-21 | 2004-08-18 | うつ病の治療のためのセロトニン再取り込み阻害剤およびグリシントランスポーター１型阻害剤の併用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060223857A1 (enExample) |
| EP (1) | EP1660130A1 (enExample) |
| JP (1) | JP2007502785A (enExample) |
| KR (1) | KR20060066729A (enExample) |
| CN (1) | CN1867358A (enExample) |
| AU (1) | AU2004266057A1 (enExample) |
| BR (1) | BRPI0413587A (enExample) |
| CA (1) | CA2536275A1 (enExample) |
| IS (1) | IS8277A (enExample) |
| MX (1) | MXPA06002002A (enExample) |
| NO (1) | NO20061167L (enExample) |
| WO (1) | WO2005018676A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100457738C (zh) * | 2001-12-20 | 2009-02-04 | H·隆德贝克有限公司 | 芳氧基苯基和芳硫基苯基衍生物 |
| WO2008100727A2 (en) * | 2007-02-14 | 2008-08-21 | The Trustees Of Columbia University In The City Of New York | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders |
| CN101338337B (zh) * | 2007-07-04 | 2011-11-02 | 北京华安佛医药研究中心有限公司 | 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒 |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| CN102949364A (zh) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | 一种含有效成分盐酸维拉佐酮的缓释片 |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL124536A (en) * | 1995-12-07 | 2001-03-19 | Daniel C Javitt | Pharmaceutical compositions containing a glycine uptake antagonist |
| US6361957B1 (en) * | 1999-08-03 | 2002-03-26 | Glytech, Inc. | Assay for D-serine transport antagonist and use for treating psychosis |
| CA2619901A1 (en) * | 1996-05-31 | 1997-12-04 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| GB2336534A (en) * | 1998-04-24 | 1999-10-27 | Alec James Coppen | Anti-depressant - Folic Acid Combination |
| DOP2001000189A (es) * | 2000-06-30 | 2002-03-30 | Pfizer Prod Inc | Benzofenonas y sulfonas como inhibidores de la captación de glicina |
| CZ2003396A3 (cs) * | 2000-07-21 | 2003-05-14 | H. Lundbeck A/S | Inhibitory transportu glycinu |
| CN100457738C (zh) * | 2001-12-20 | 2009-02-04 | H·隆德贝克有限公司 | 芳氧基苯基和芳硫基苯基衍生物 |
| EP1545552B1 (en) * | 2002-06-20 | 2007-03-28 | H. Lundbeck A/S | Combination therapy wherein a serotonin reuptake inhibitor is used |
| AU2004251636B2 (en) * | 2003-05-27 | 2006-11-09 | Merz Pharma Gmbh & Co. Kgaa | Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
-
2004
- 2004-08-18 WO PCT/DK2004/000547 patent/WO2005018676A1/en not_active Ceased
- 2004-08-18 EP EP04739042A patent/EP1660130A1/en not_active Withdrawn
- 2004-08-18 KR KR1020067003210A patent/KR20060066729A/ko not_active Withdrawn
- 2004-08-18 US US10/568,133 patent/US20060223857A1/en not_active Abandoned
- 2004-08-18 CN CNA2004800304533A patent/CN1867358A/zh active Pending
- 2004-08-18 AU AU2004266057A patent/AU2004266057A1/en not_active Abandoned
- 2004-08-18 CA CA002536275A patent/CA2536275A1/en not_active Abandoned
- 2004-08-18 BR BRPI0413587-3A patent/BRPI0413587A/pt not_active IP Right Cessation
- 2004-08-18 JP JP2006523530A patent/JP2007502785A/ja not_active Withdrawn
- 2004-08-18 MX MXPA06002002A patent/MXPA06002002A/es not_active Application Discontinuation
-
2006
- 2006-01-31 IS IS8277A patent/IS8277A/is unknown
- 2006-03-13 NO NO20061167A patent/NO20061167L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8754119B2 (en) | Use of rotigotine for the treatment of depression | |
| RU2445973C2 (ru) | Способ лечения глубокой депрессии у человека | |
| JP2008536946A (ja) | うつ病の処置または予防のための新規の治療的組み合わせ | |
| JP2008531714A (ja) | 不安障害の治療用及び／又は予防用の医薬組成物 | |
| KR20090029200A (ko) | 우울증 질환에 대한 치료 | |
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| JP2011523949A5 (enExample) | ||
| BRPI0610037A2 (pt) | derivados de dihidrobenzofurano e uso dos mesmos | |
| CA2567249A1 (en) | Lithium combinations, and uses related thereto | |
| JP2007513052A5 (enExample) | ||
| JP2007502785A5 (enExample) | ||
| JP2006522030A5 (enExample) | ||
| CA2488138A1 (en) | Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent | |
| Khawaja et al. | Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants | |
| HRP20120713T1 (hr) | Kombinacija analeptičkog modafinila i antidepresiva za liječenje depresije | |
| JP2007513896A5 (enExample) | ||
| UA84692C2 (ru) | Фармацевтическая композиция, содержащая арипипразол и ингибитор повторного усвоения серотонина, и ее использование для лечения расстройств настоения | |
| MXPA06002002A (es) | La combinacion de un inhibidor de reabsorcion de serotonina y un inhibidor de transportador de glicina tipo 1 para el tratamiento de depresion. | |
| US20060217394A1 (en) | Treatment of anhedonia | |
| CA2342585A1 (en) | A new composition | |
| AU2007283530A1 (en) | Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination | |
| EP1928448B1 (fr) | ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE | |
| TH86939A (th) | อนุพันธ์ไดแอริลและแอริลเฮเทโรแอริลยูเรียเป็นมอดูเลเตอร์ของ5-ht2a เซอโรโทนินรีเซปเตอร์ที่มีประโยชน์สำหรับการป้องกันและการบำบัดความผิดปกติที่เกี่ยวกับมัน | |
| TH75120B (th) | อนุพันธ์ไดแอริลและแอริลเฮเทโรแอริลยูเรียเป็นมอดูเลเตอร์ของ5-ht2a เซอโรโทนินรีเซปเตอร์ที่มีประโยชน์สำหรับการป้องกันและการบำบัดความผิดปกติที่เกี่ยวกับมัน | |
| Hamon | C. 15.02 Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects? |